Evolutionary Genomics, Inc. (FNAM)

Other OTC - Other OTC Delayed Price. Currency in USD

0.4500

0.0000

(0.00%)

As of 03:26PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.4500
Open	0.4500
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.4500 - 0.4500
52 Week Range	0.4500 - 0.7200
Volume	300
Avg. Volume	37

Market Cap	2.995M
Beta (5Y Monthly)	-0.20
PE Ratio (TTM)	N/A
EPS (TTM)	-0.3500
Earnings Date	Oct 04, 2023 - Oct 05, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FNAM

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

EVOLUTIONARY GENOMICS INC
Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Rating
Fair Value
Economic Moat
26 days agoMorningstar